Patients with rheumatoid arthritis-associated lung disease demonstrate a significant increased risk for serious infection vs.
Newco Elevara Medicines Ltd. has raised $70 million in a series A to fund a phase IIa/IIb trial of ELV-001, a first-in-class, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback